CA1019723A - Sedative peptides - Google Patents

Sedative peptides

Info

Publication number
CA1019723A
CA1019723A CA176,197A CA176197A CA1019723A CA 1019723 A CA1019723 A CA 1019723A CA 176197 A CA176197 A CA 176197A CA 1019723 A CA1019723 A CA 1019723A
Authority
CA
Canada
Prior art keywords
sedative
peptides
sedative peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA176,197A
Other languages
English (en)
Other versions
CA176197S (en
Inventor
Hendrik M. Greven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzona Inc
Original Assignee
Akzona Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzona Inc filed Critical Akzona Inc
Application granted granted Critical
Publication of CA1019723A publication Critical patent/CA1019723A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA176,197A 1972-07-15 1973-07-11 Sedative peptides Expired CA1019723A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7209839,A NL175618C (nl) 1972-07-15 1972-07-15 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Publications (1)

Publication Number Publication Date
CA1019723A true CA1019723A (en) 1977-10-25

Family

ID=19816526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA176,197A Expired CA1019723A (en) 1972-07-15 1973-07-11 Sedative peptides

Country Status (13)

Country Link
US (1) US3853838A (enExample)
JP (1) JPS5936611B2 (enExample)
AU (1) AU471401B2 (enExample)
BE (1) BE802335A (enExample)
CA (1) CA1019723A (enExample)
CH (1) CH605674A5 (enExample)
DE (1) DE2335826C2 (enExample)
FR (1) FR2192838B1 (enExample)
GB (1) GB1439225A (enExample)
HU (1) HU169437B (enExample)
NL (1) NL175618C (enExample)
SE (1) SE392721B (enExample)
ZA (1) ZA734648B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607683A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4144228A (en) * 1976-05-07 1979-03-13 G. D. Searle & Co. Methionine5 -enkephalin sulfoxides and sulfones
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
RU2315057C2 (ru) * 2006-02-17 2008-01-20 Закрытое акционерное общество "Синтез пептидов" Способ получения аналогов аденокортикотропного гормона (актг), последовательности (4-10), обладающих нейротропной активностью, и тетрапептид для его получения
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278010A (enExample) * 1961-05-04 1900-01-01
NL6509727A (enExample) * 1965-07-28 1967-01-30
GB1230472A (enExample) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
NL175618B (nl) 1984-07-02
FR2192838B1 (enExample) 1977-01-28
HU169437B (enExample) 1976-11-28
NL7209839A (enExample) 1974-01-17
US3853838A (en) 1974-12-10
CH605674A5 (enExample) 1978-10-13
DE2335826A1 (de) 1974-01-31
JPS5936611B2 (ja) 1984-09-05
DE2335826C2 (de) 1984-01-05
JPS4951278A (enExample) 1974-05-18
FR2192838A1 (enExample) 1974-02-15
ZA734648B (en) 1974-06-26
SE392721B (sv) 1977-04-18
AU471401B2 (en) 1976-04-29
BE802335A (fr) 1974-01-14
AU5798373A (en) 1975-01-16
NL175618C (nl) 1984-12-03
GB1439225A (en) 1976-06-16

Similar Documents

Publication Publication Date Title
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU454372B2 (en) Childsafe actuator-overcap
AU477190B2 (en) Polypeptides
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU471401B2 (en) Sedative peptides
AU6147073A (en) Peptides
AU474971B2 (en) Polypeptides
AU475748B2 (en) Napnthopyrans
AU475339B2 (en) S-substituted-2-thiodenosines
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
AU468159B2 (en) 5-aroyl-furans
AU466344B2 (en) Cycloalkyllactamimides
AU468599B2 (en) 15-oxasteroids
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU467526B2 (en) Pyronorifamycins
AU473297B2 (en) Indolylimidoylheterocyclics
AU472554B2 (en) Isothocyanobenzoxazoles
AU475257B2 (en) Benzodiazepines
AU460536B2 (en) Triazolobenzophenones
AU469608B2 (en) Oxainoquinazolinones
AU473061B2 (en) 3-aminohydroxypropoxy-2-substituted-4-pyranones
AU474168B2 (en) Anilinobenzothiazoles
AU451103B2 (en) 1-alkylidene-3-indenyl echanols
AU477577B2 (en) Amidinoureas